Search studies

6 studies found

203167 Phase 2a in Psoriasis
ELU-4-EA431B-1

Psoriasis Phase 2a clinical study.

204869 Phase 2a/b in Ulcerative Colitis
ELU-4-907C53-1

204869 Phase 2a/b in Ulcerative Colitis

AMCUC study
ELU-4-54A576-1

AMCUC study

LUCENT-1 (NCT 03518086)
ELU-4-58F581-1

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

OncoTrack study
ELU-4-24D114-1

OncoTrack attempts to address the core problems of drug-based cancer therapies: the low response rate of patients to their therapies, as well as its inevitable consequence, the low approval rates of oncology drugs. Only about 10% of cancer drug candidates entering clinical development are granted marketing authorization. Our program is based on two seminal developments: significant progress in our ability to analyze the molecular characteristics of individual tumors and patients (predominantl...

Pfizer (NCT02958865)
ELU-4-B16B4B-1

The Pfizer UC dataset represents baseline, placebo and treatment (PF-06700841) subject and sample-level data extracted from a phase 2 study in moderate to severe ulcerative colitis.